Recombinant human lactoferrin regulatory update

Agennix received two U.S. Patents (Nos. 5,766,939 and 5,849,881) covering the production of recombinant lactoferrin, an antimicrobial/anti-inflammatory protein, and lactoferrin polypeptides. ...